Category: News

Biannual Amyloidosis Support Group Comes to Penn Medicine on March 28

Join The Amyloidosis Program at Penn Medicine and the Amyloidosis Support Group Saturday, March 28 from 9 am to 2:30 pm for the biannual Amyloidosis Support Group. In partnership with the Amyloidosis Support Group, Penn Medicine's Amyloidosis Pro...

Focus on Cancer RSS Feed 2015-03-13 12:54:00

Join The Amyloidosis Program at Penn Medicine and the Amyloidosis Support Group Saturday, March 28, 2015 from 9 am to 2:30 pm for the biannual Amyloidosis Support Group. In partnership with the Amyloidosis Support Group, Penn Medicine's Amyloido...

Melphalan, Antimelanoma Immunity, Inflammation

Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger signals in dying cancer cells that can incite protective antitumor immunity. In this study, ...

Anti-tumor immunity triggered by melphalan is potentiated by melanoma cell surface associated calreticulin

Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger signals in dying cancer cells that can incite protective antitumor immunity. In this study, w...

Keeping Your Hair In Chemo

A growing number of breast cancer patients are freezing their scalps as a way to preserve their hair during chemotherapy.